Results 91 to 100 of about 8,456 (172)

Thyroid-Associated Orbitopathy: Who and How to Treat

Thyroid-associated orbitopathy is the most frequent and troublesome nonthyroidal complication of Graves\u27 disease. It is mandatory to determine whether sight-threatening orbitopathy is present, as this requires prompt and aggressive treatment ...
Dickinson J, Perros P
core  

Complications after radiotherapy in patients with Graves' orbitopathy: A nationwide cohort study. [PDF]

Eye (Lond)
Lee J, Ahn HY, Heo JS, Kim M, Lee JK.
europepmc   +1 more source

Pediatric Graves' orbitopathy: TRAb and FT-3 are also prognostic factors in children-A tertiary center study. [PDF]

Thyroid Res
Al-Ghazzawi K, Oeverhaus M, Rama A, Kiewert C, Bechrakis N, Chen Y, Neumann I, Eckstein A.   +7 more
europepmc   +1 more source

Thyroid orbitopathy

Radiologia Brasileira
openaire   +3 more sources

New Advances and Perspectives in Ophthalmology: Progress and Modern Challenges Toward Personalized Eye Care. [PDF]

J Pers Med
Vitiello L.
europepmc   +1 more source

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim W, Seo MK, Kim YJ, Choi SH, Ku CR, Kim S, Lee EJ, Yoon JS.   +7 more
europepmc   +1 more source

Quality of life in refractory Graves' hyperthyroidism: a cross-sectional study comparing long-term ATDs therapy versus L-T4 replacement after iodine-131. [PDF]

Front Endocrinol (Lausanne)
Yuan A, Yan Z, Wu J, Song Y, Huang H.
europepmc   +1 more source

Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions. [PDF]

Int J Mol Sci
Periferakis A, Troumpata L, Xefteris I, Mavrokefalos AK, Periferakis AT, Periferakis K, Caruntu A, Scheau AE, Dragosloveanu CDM, Caruntu C, Scheau C.   +10 more
europepmc   +1 more source